1. Medoh, Uche N, Hims, Andy, Chen, Julie Y, Dong, Wentao, Abu-Remaileh, Monther. 2023. The Batten disease gene product CLN5 is the lysosomal bis(monoacylglycero)phosphate synthase. In Science (New York, N.Y.), 381, 1182-1189. doi:10.1126/science.adg9288. https://pubmed.ncbi.nlm.nih.gov/37708259/
2. Murray, Samantha J, Wellby, Martin P, Barrell, Graham K, Palmer, David N, Mitchell, Nadia L. 2023. Efficacy of dual intracerebroventricular and intravitreal CLN5 gene therapy in sheep prompts the first clinical trial to treat CLN5 Batten disease. In Frontiers in pharmacology, 14, 1212235. doi:10.3389/fphar.2023.1212235. https://pubmed.ncbi.nlm.nih.gov/37942487/
3. Basak, I, Wicky, H E, McDonald, K O, Schoderboeck, L, Hughes, S M. 2021. A lysosomal enigma CLN5 and its significance in understanding neuronal ceroid lipofuscinosis. In Cellular and molecular life sciences : CMLS, 78, 4735-4763. doi:10.1007/s00018-021-03813-x. https://pubmed.ncbi.nlm.nih.gov/33792748/
4. Kim, William D, Huber, Robert J. 2022. An altered transcriptome underlies cln5-deficiency phenotypes in Dictyostelium discoideum. In Frontiers in genetics, 13, 1045738. doi:10.3389/fgene.2022.1045738. https://pubmed.ncbi.nlm.nih.gov/36437924/
5. Murray, Samantha J, Russell, Katharina N, Melzer, Tracy R, Palmer, David N, Mitchell, Nadia L. 2021. Intravitreal gene therapy protects against retinal dysfunction and degeneration in sheep with CLN5 Batten disease. In Experimental eye research, 207, 108600. doi:10.1016/j.exer.2021.108600. https://pubmed.ncbi.nlm.nih.gov/33930398/
6. Huber, Robert J, Mathavarajah, Sabateeshan. 2017. Cln5 is secreted and functions as a glycoside hydrolase in Dictyostelium. In Cellular signalling, 42, 236-248. doi:10.1016/j.cellsig.2017.11.001. https://pubmed.ncbi.nlm.nih.gov/29128403/
智鼠故事 
